Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

RECRUITING NA

Retrieval-based Word Learning in Developmental Language Disorder: Adaptive Retrieval Schedule

NCT06995014 · View on ClinicalTrials.gov ↗

Study Summary

Children with developmental language disorder (DLD; also referred to as specific language impairment) experience a significant deficit in language ability that is longstanding and harmful to the children's academic, social, and eventual economic wellbeing. Word learning is one of the principal weaknesses in these children. This project focuses on the word learning abilities of four- and five-year-old children with DLD. The goal of the project is to determine whether special benefits accrue when these children must frequently recall newly introduced words during the course of learning. In the current study, the investigators compare a "standard" repeated spaced retrieval schedule, with fixed spacing between hearing a word and attempting to retrieve it, to an "adaptive" repeated spaced retrieval schedule in which opportunities to retrieve a given word are tailored to the individual child's current knowledge state. The goal of the study is to determine whether the adaptive schedule can increase children's absolute levels of learning while maintaining the advantages of repeated spaced retrieval.

Interventions

  • BEHAVIORAL Retrieval-based word learning: Standard retrieval practice schedule
  • BEHAVIORAL Retrieval-based word learning: Adaptive retrieval practice schedule

Study Locations (1)

Indiana

  • Purdue University — West Lafayette

Trial Details

FieldValue
Enrollment Target 32 participants
Start Date 2024-08-15
Est. Completion 2025-12-31
Phase NA

Sponsor

Purdue University

100 total trials

Interested in This Trial?

Always speak with your doctor before enrolling in a clinical trial.

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06995014

The ClinicalTrials.gov registry entry for NCT06995014 describes a study currently listed as recruiting. It is categorized as NA, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Purdue University, which has 100 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.

The record links to 3 conditions, with Developmental Language Disorder appearing as the primary indexed condition, and to 2 interventions — of which Retrieval-based word learning: Standard retrieval practice schedule is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.

Geographic footprint matters for practical reasons: NCT06995014 reports 1 study location spanning 1 distinct geographic area — top geographies include Indiana. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.

Frequently Asked Questions

What is clinical trial NCT06995014 about?

NCT06995014 is a clinical study titled "Retrieval-based Word Learning in Developmental Language Disorder: Adaptive Retrieval Schedule". Children with developmental language disorder (DLD; also referred to as specific language impairment) experience a significant deficit in language ability that is longstanding and harmful to the children's academic, social, and eventual economic wellbeing. Word learning is one of the principal weakn...

What is the current status of trial NCT06995014?

This trial is currently recruiting. It is a NA study. The enrollment target is 32 participants. The study started on 2024-08-15. Estimated completion is 2025-12-31.

What conditions does trial NCT06995014 study?

This clinical trial studies the following conditions: Developmental Language Disorder, Language Development, Specific Language Impairment. These conditions were identified from the trial registry and reflect the primary focus areas of the research.

What interventions are being tested in trial NCT06995014?

The interventions under investigation include: Retrieval-based word learning: Standard retrieval practice schedule (BEHAVIORAL), Retrieval-based word learning: Adaptive retrieval practice schedule (BEHAVIORAL). Each intervention is being evaluated for safety and efficacy as part of this clinical study.

Who is sponsoring clinical trial NCT06995014?

This trial is sponsored by Purdue University, which has 100 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.

Where is trial NCT06995014 being conducted?

This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Related

Data sourced from official U.S. government datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial